Marker Therapeutics, Inc.MRKRNASDAQ
LOADING
|||
Switch Symbol:
Operating Income Scaling
Trending higher, above historical average, modest growth trend.
Left:
||||
Profit from core business operations before interest and taxes
Latest
$-11.12M
↑ 64% above average
Average (9y)
$-31.07M
Historical baseline
Range
High:$-6.16M
Low:$-148.17M
CAGR
+6.8%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-11.12M | +23.7% |
| 2023 | $-14.58M | +26.3% |
| 2022 | $-19.79M | +49.9% |
| 2021 | $-39.48M | -36.7% |
| 2020 | $-28.89M | -28.2% |
| 2019 | $-22.53M | +84.8% |
| 2018 | $-148.17M | -1190.7% |
| 2017 | $-11.48M | -35.2% |
| 2016 | $-8.49M | -37.9% |
| 2015 | $-6.16M | - |